Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.8M | $7.7M | $21.1M | $74.1M | $114.5M | $188.9M | $237.1M | $223.4M |
| Cost of revenue | $2.6M | $4.3M | $11.7M | $43.7M | $65.4M | $93.0M | $135.4M | $137.7M |
| Gross profit | $1.2M | $3.4M | $9.4M | $30.4M | $49.2M | $95.9M | $101.7M | $85.6M |
| Gross margin | 30.8% | 44.4% | 44.6% | 41.1% | 42.9% | 50.8% | 42.9% | 38.3% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$1.9M | −$7.0M | −$68.7M | −$178.0M | −$143.1M | $614.0K | −$5.4M | −$31.1M |
| EBITDA | −$1.9M | −$7.0M | −$22.4M | −$181.4M | −$355.2M | −$20.8M | −$120.6M | −$5.3M |
| Net income | −$1.9M | −$8.5M | −$205.7M | −$195.2M | −$360.1M | −$73.2M | −$168.7M | −$69.1M |
| Net margin | -51.6% | -110.3% | -973.6% | -263.3% | -314.4% | -38.7% | -71.1% | -30.9% |
| EPS (diluted) | -0.02 | -0.13 | -3.08 | -2.26 | -3.60 | -0.70 | -1.54 | -0.61 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds ACRHF.
No tracked institution reports a position in ACRHF as of their last filing.
No one on the platform has traded ACRHF yet.
| +0.93% |
| $4M |
| — |
| HDRPFEpsilon Healthcare Limited | $0.00 | +0.00% | $544746 | — |
| IPCIFIntellipharmaceutics International Inc. | $0.15 | — | $5M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.0× sales vs its 0.5× historical median P/S.
Fair value ≈ $0.97 · price $0.00 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$ACRHF Is anybody aware of any class action lawsuits? I should have known better not to invest in this corrupt company! Just think about it: These filths employed former House Speaker John Boehner to lobby for marijuana legalization in DC. Let that sink in! The filth that opposed marijuana in Congress all his life long makes millions from investors' money to lobby for it after his career ends in DC. I should have known better not to trust the filths in ACREAGE.
View on StockTwits ↗$ACRHF wow just noticed this has entirely disappeared from my portfolio….delisted???
View on StockTwits ↗$ACRHF shoot new year to acreage bah holders
View on StockTwits ↗$ACRHF Given this more thought and would expect the corporate lawyers have covered their shady positions in confusing clauses and tiny print. Perhaps the new CEO, Luc Mongeau will decide to redeem worthless Fixed Shares and reissue them within 30 days of closing the deal. Otherwise, 2024 tax write off may be the only way to recover losses.
View on StockTwits ↗$ACRHF Welcome to the Greatest Company...... You are Now CGC............. We are having the Biggest Party here at Canopy Growth.......
View on StockTwits ↗$ACRHF Welcome to CGC.... Start Buying and Holding. Its going to get real............. Up Up and AWAY in 2025!!!!!!! Loading up now.
View on StockTwits ↗$CGC $ACRHF Shareholders who were misled by Acreage’s failure to disclose material adverse conditions are encouraged to reply to my personal email: silverdiscgolfer@gmail.com I’m considering filing a civil lawsuit in District court next week seeking treble and non-economic compensatory damages. I’ve reached out to Canopy leadership and waiting on their response before taking next steps.
View on StockTwits ↗$ACRHF Welcome to CGC....... Start Buying CGC........ You are in Good Hands.......
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.